Ekso Bionics Holdings, Inc.

LSE:0IFR Stock Report

Market Cap: US$23.1m

Ekso Bionics Holdings Past Earnings Performance

Past criteria checks 0/6

Ekso Bionics Holdings has been growing earnings at an average annual rate of 8.2%, while the Medical Equipment industry saw earnings declining at 5.9% annually. Revenues have been growing at an average rate of 8.3% per year.

Key information

8.2%

Earnings growth rate

38.9%

EPS growth rate

Medical Equipment Industry Growth-9.5%
Revenue growth rate8.3%
Return on equity-25.2%
Net Margin-19.8%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Ekso Bionics Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

LSE:0IFR Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2418-4184
31 Dec 2318-15204
30 Sep 2317-15204
30 Jun 2316-16214
31 Mar 2314-15203
31 Dec 2213-15193
30 Sep 2213-15203
30 Jun 2213-12193
31 Mar 2212-11192
31 Dec 2111-10192
30 Sep 219-11162
30 Jun 219-6152
31 Mar 219-17152
31 Dec 209-16162
30 Sep 2010-15162
30 Jun 2011-17172
31 Mar 2012-8193
31 Dec 1914-12194
30 Sep 1913-14225
30 Jun 1913-21225
31 Mar 1912-26245
31 Dec 1811-27265
30 Sep 1810-32266
30 Jun 1810-31277
31 Mar 188-29268
31 Dec 177-29249
30 Sep 177-26229
30 Jun 177-312210
31 Mar 177-35229
31 Dec 1614-34218
30 Sep 1614-38218
30 Jun 1615-31198
31 Mar 1615-27187
31 Dec 159-24176
30 Sep 158-35165
30 Jun 157-18155
31 Mar 15644144
31 Dec 145-34154
30 Sep 145-16123
30 Jun 144-30112
31 Mar 144-9093
31 Dec 133-1292
30 Sep 133-1393

Quality Earnings: 0IFR is currently unprofitable.

Growing Profit Margin: 0IFR is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0IFR is unprofitable, but has reduced losses over the past 5 years at a rate of 8.2% per year.

Accelerating Growth: Unable to compare 0IFR's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 0IFR is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (17.9%).


Return on Equity

High ROE: 0IFR has a negative Return on Equity (-25.24%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.